未登录

H

Hani M. Hafez

al-esraa university

H指数:9

被引数:276

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LC-MS/MS Method Development and Validation for Clinical Pharmacokinetics and Therapeutic Drug Monitoring of Potassium-Competitive Acid Blocker Vonoprazan-Based Triple Therapy for H. pylori in Human Plasma

人血浆中用于幽门螺杆菌（H. pylori）治疗的钾竞争性酸阻滞剂沃诺拉赞为基础的三联疗法临床药代动力学及治疗药物监测的LC-MS/MS方法开发与验证

Pharmaceuticals 2025, Vol. 18, Page 1509

IF4.8

2025-10-080

OAAI

Design, synthesis, and computational studies of novel pyrazoline-based dual EGFR/HER-2 inhibitors with apoptotic antiproliferative activity

基于吡唑烷的新型EGFR/HER-2双重抑制剂的设计、合成及计算研究，该抑制剂具有诱导凋亡的抗增殖活性。

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-05-170

PRE

Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazoline-based derivatives as dual EGFR and HER-2 inhibitors

以吡唑烷为基础的衍生物的设计、合成、抗增殖活性及作为EGFR和HER-2双重抑制剂的分子动力学模拟

IF4.6

2025-01-010

OA

Isoquinoline-based intrinsic fluorescence assessment of erythropoiesis-stimulating agent, Roxadustat (FG-4592), in tablets: applications to content uniformity and human plasma evaluation

IF3

2024-04-112

PRE

Micellar Organic-solvent free HPLC design of experiment for the determination of Ertapenem and meropenem; assessment using GAPI, AGREE and analytical Eco-scale models

MICROCHEMICAL JOURNAL

IF5.1

2023-02-0130

PRE

Application of molecular docking approach in a novel eco-friendly impurity profiling HPLC-UV method for the simultaneous estimation of ternary hypoglycemic pharmaceutical mixture

MICROCHEMICAL JOURNAL

IF5.1

2022-11-0110

PRE

Synthesis, antiproliferative activity, and molecular modeling of novel 4-methylcoumarin derivatives and/or nitric oxide donor hybrids

MOLECULAR DIVERSITY

IF3.8

2022-10-222

PRE

Development of a solvent-free micellar HPLC method for determination of five antidiabetic drugs using response surface methodology

MICROCHEMICAL JOURNAL

IF5.1

2022-08-0118

PRE